RESUMO
Multidrug-resistant bacterial infections are a threat to public health worldwide, which boosts the urgent need for pharmacological research for new drugs. Although the peptides without disulfide bridges from scorpions have shown antimicrobial action, usually their toxicity hamper their pharmacological application. Stigmurin is a non-hemolytic cationic peptide from Tityus stigmurus venom with antibacterial effect and toxicity on normal cells. In this approach, the conformational changes and stability of two Stigmurin analog peptides, named StigA8 and StigA18, were evaluated by circular dichroism, as well as the mechanism of interaction with bacterial membranes in silico. In addition, the in vitro and in vivo antibacterial activity and the action against the biofilm formed by multidrug-resistant Staphylococcus aureus were investigated. StigA8 (+4) and StigA18 (+5) revealed the ability to change their structural conformation depending on the medium composition, and high stability at different temperatures and pH conditions. Both analog peptides showed greater ability to interact with bacterial membranes in silico when compared to the native one. StigA8 and StigA18 demonstrated low hemolytic action, with non-toxic effect on G. mellonella larvae up to 120 mg/kg. StigA8 and StigA18 presented a broad spectrum of antibacterial action in vitro, especially against multidrug-resistant clinical isolates. The analog peptides (7.5 µM) also reduced the biofilm biomass of multidrug-resistant S. aureus, as well as increased the larval survival of the Galleria mellonella infected larvae. Therefore, StigA8 and StigA18 showed a beneficial potential in the treatment of bacterial infections, constituting promising bioactive components for the development of new antimicrobial agents.
Assuntos
Staphylococcus aureus Resistente à Meticilina , Venenos de Escorpião , Animais , Antibacterianos/farmacologia , Bactérias , Biofilmes , Testes de Sensibilidade Microbiana , Peptídeos/química , Peptídeos/farmacologia , Venenos de Escorpião/química , Venenos de Escorpião/farmacologia , Escorpiões/químicaRESUMO
INTRODUCTION: Pseudomonas aeruginosa is an opportunistic pathogen associated with healthcare-related infections, affecting mainly patients with underlying diseases and immunosuppression. This microorganism has several virulence mechanisms that favour its pathogenesis, including the production of biofilm. This study aimed to analyze the phenotypic production of biofilms, the occurrence of quorum sensing (QS) genes, and the clonal profile of clinical isolates of P. aeruginosa from colonized/infected patients in a tertiary hospital in Recife-PE. METHODS: We obtained 21 isolates that were classified as infection isolates (II), and 10 colonization isolates (CI). The phenotypic analysis for biofilm production was performed quantitatively. The QS genes were detected by specific PCRs, and the clonal profile was assessed using ERIC-PCR. RESULTS: Of the 31 isolates, 58.1 % (18/31) were biofilm producers, of which 70 % (7/10) were CI and classified as weakly adherent; 52.4 % (11/21) of the II produced biofilms, and were classified as weak (38.1 %, (8/21)), moderate (9.5 %, (2/21)), and strongly adherent (4.8 %, (1/21)). All isolates harbored the QS genes analyzed. In the clonal analysis, 26 distinct genetic profiles were identified, highlighting the presence of a clone in four samples, i.e., one infection isolate, and 3 colonization isolates. CONCLUSIONS: The detection of biofilm formation is important in P. aeruginosa in addition to the identification of colonization and infection isolates, especially from complex environments such as ICUs. Further, we define a strategy for monitoring and analyzing P. aeruginosa strains that can potentially cause infections in hospitalized patients.
Assuntos
Infecções por Pseudomonas , Pseudomonas aeruginosa , Antibacterianos/farmacologia , Biofilmes , Genótipo , Humanos , Fenótipo , Pseudomonas aeruginosa/genética , Percepção de Quorum/efeitos dos fármacos , Virulência/genética , Fatores de VirulênciaRESUMO
Abstract INTRODUCTION: Pseudomonas aeruginosa is an opportunistic pathogen associated with healthcare-related infections, affecting mainly patients with underlying diseases and immunosuppression. This microorganism has several virulence mechanisms that favour its pathogenesis, including the production of biofilm. This study aimed to analyze the phenotypic production of biofilms, the occurrence of quorum sensing (QS) genes, and the clonal profile of clinical isolates of P. aeruginosa from colonized/infected patients in a tertiary hospital in Recife-PE. METHODS: We obtained 21 isolates that were classified as infection isolates (II), and 10 colonization isolates (CI). The phenotypic analysis for biofilm production was performed quantitatively. The QS genes were detected by specific PCRs, and the clonal profile was assessed using ERIC-PCR. RESULTS: Of the 31 isolates, 58.1 % (18/31) were biofilm producers, of which 70 % (7/10) were CI and classified as weakly adherent; 52.4 % (11/21) of the II produced biofilms, and were classified as weak (38.1 %, (8/21)), moderate (9.5 %, (2/21)), and strongly adherent (4.8 %, (1/21)). All isolates harbored the QS genes analyzed. In the clonal analysis, 26 distinct genetic profiles were identified, highlighting the presence of a clone in four samples, i.e., one infection isolate, and 3 colonization isolates. CONCLUSIONS: The detection of biofilm formation is important in P. aeruginosa in addition to the identification of colonization and infection isolates, especially from complex environments such as ICUs. Further, we define a strategy for monitoring and analyzing P. aeruginosa strains that can potentially cause infections in hospitalized patients.
Assuntos
Humanos , Pseudomonas aeruginosa/genética , Infecções por Pseudomonas , Fenótipo , Virulência/genética , Biofilmes , Fatores de Virulência , Percepção de Quorum/efeitos dos fármacos , Genótipo , Antibacterianos/farmacologiaAssuntos
Adulto , Antibacterianos , Antibacterianos , Antibacterianos , Sobrevivência Celular , Células Cultivadas , Combretaceae , Citocinas , Humanos , Fatores Imunológicos , Fatores Imunológicos , Leucócitos Mononucleares , Leucócitos Mononucleares , Linfócitos , Linfócitos , Testes de Sensibilidade Microbiana , Extratos Vegetais , Extratos Vegetais , Extratos Vegetais , Pseudomonas aeruginosa , Staphylococcus aureus , Adulto JovemRESUMO
Arrabidaea harleyi A.H. Gentry (Bignoniaceae) is an ornamental plant found in some regions of the Atlanticforest in Brazil. From its bark a mixture of verbascoside and isoverbascoside was isolated. This mixture was shown to be active against Staphylococcus aureus, Micrococcus luteus, Bacillus subtilis, Bacillus mycoides, Enterecoccus faecalis, Escherichia coli, Serratia marcensis and Candida albicans. The minimal inhibitory concentration (MIC) was established by diffusion method
Assuntos
Farmacognosia , Plantas Medicinais , Extratos Vegetais , Caules de PlantaRESUMO
Streptoverticillium sp, bactéria pertencente a família Streptomycetaceae, foi isolada de amostras de solo do câmpus da Universidade Federal do Pernambuco, e destacou-se pela atividade antibacteriana e antifúngica de seus matabólitos secundários. O extrato etanóico bruto foi submetido ao fracionamento cromatográfigo. Das substâncias isoladas, duas apresentaram atividade antimicrobiana em relação a sete espécies de Candida. Em testes biológicos realizados em camundongos, determinou-se que a maior dose do extrato bruto na qual não houve óbitos foi de 150 mg/kg e todos os animais morreram com a administração de 600 mg/kg. Para o extrato etanóico de Streptoverticillium sp observou-se IC50 de 13 ug/mL e taxa de inibição tumoral igual a 61,5 por cento para o carcinoma de Ehrlich e 75 por cento em animais com sarcoma 180.
Assuntos
Ratos , Antifúngicos , Antifúngicos , Candida albicans , Citotoxicidade Imunológica , Streptomycetaceae , Antibacterianos/toxicidadeRESUMO
Arrabidaea harleyi A.H. Gentry (Bignoniaceae) is an ornamental plant found in some regions of the Atlantic forest in Brazil. From its bark a mixture of verbascoside and isoverbascoside was isolated. This mixture was shown to be active against Staphylococcus aureus, Micrococcus luteus, Bacillus subtilis, Bacillus mycoides, Enterecoccus faecalis, Eschrichia coli, Serratia marcensis and Candida albicans. The minimal inhibitory concentration (MIC) was established by diffusion method(AU)